Duloxetine Versus Pregabalin for Alcohol Dependence
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
A 12-week, double-blind, placebo-controlled parallel group study will be conducted with 150
outpatients with alcohol dependence, with random assignment to pregabalin 300 mg/d,
duloxetine 40 mg/d, or placebo in conjunction with manual-guided behavioral counseling and
follow-up visits 1 week and 3 months post-treatment.
Phase:
Phase 2
Details
Lead Sponsor:
The Scripps Research Institute
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)